Method Medical Media launches
London-based agency begins trading today - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/method_medical_media_launches_1204334
Search results
Found 321 pages
AUTHOR: George Underwood
Lansons recruits Kate Aldous
Appointment boosts healthcare offering - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021Loud and clear - PharmaTimes Magazine January 2018
We asked the winning companies from the 2017 Communications Team of the Year competition what pharma’s comms priorities should be - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/janfeb/loud_and_clearBayer halts Xarelto trial
Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036New general manager for Abbie UK
- Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/new_general_manager_for_abbie_uk_1195687Age of discovery - PharmaTimes Magazine November 2017
Five years on from Pfizer selling Discovery Park, the site’s current chief executive Toby Hunter tells PharmaTimes about the plans for its future - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2017/november_2017/age_of_discoveryMerck discontinues HCV programmes
Company will focus on existing HCV drug ZEPATIER - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/merck_discontinues_hcv_programmes_120660690TEN boosts PR division
New hires from Bisector 2 and Tonic - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/90ten_boosts_pr_division_1022156Company focus: Perspectum Diagnostics - PharmaTimes Magazine April…
How this Oxford spinout is using AI to tackle challenges in non-alcoholic fatty liver disease - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/april_2018/company_focus_perspectum_diagnosticsHumira gets EC approval for anterior uveitis
Humira is now the only EU biologic treatment option for children with the disease - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/humira_gets_ec_approval_for_anterior_uveitis_1205082
